DigiNepal Health ENनेहि

← स्वास्थ्य · औषधि

💊 Daunorubicin

💊 यो जानकारी मात्र हो, प्रिस्क्रिप्सन होइन। कुनै पनि औषधि लिनुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। ओभरडोज वा विषाक्तता भए १०२ मा फोन गर्नुहोस्।

Common side effects

Other reactions include: Cutaneous Reversible alopecia occurs in most patients. Rash, contact dermatitis and urticaria have occurred rarely. Gastrointestinal Acute nausea and vomiting occur but are usually mild. Antiemetic therapy may be of some help. Mucositis may occur 3 to 7 days after administration. Pregnancy (label summary): Daunorubicin hydrochloride may cause fetal harm when administered to a pregnant woman. Decreases in fetal birth weight and post-delivery growth rate were observed in mice. There are no adequate and well-controlled studies in pregnant women. Breastfeeding (label summary): Nursing Mothers It is not known whether this drug is excreted in human milk. General information only, not medical advice and not a prescription. No doses are given. Always consult a doctor or pharmacist before starting, stopping or changing any medicine, especially in pregnancy, breastfeeding, children, older age or with other medicines.

🚨 ओभरडोज वा विषाक्तता

ओभरडोज वा विषाक्तता शंका भए अहिले नै १०२ मा फोन गर्नुहोस्।

📞 १०२

स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference

US FDA DailyMed; NLM RxNorm

आपत्काल — फोन📞 102